Trial Innovation Network

What is the Trial Innovation Network? The Trial Innovation Network is a collaborative initiative of the National Center for Advancing Translational Sciences (NCATS) that seeks to address critical roadblocks in clinical trials and accelerate the translation of novel research into clinical practice. Through its CTSA grant, Case Western Reserve University has become a member of the Trial Innovation Network which will provide study investigators with a broad range of services and consultations to optimize clinical trials and studies. These services and consultations are designed to help investigators develop proposals into protocols, optimize study operations, and enhance recruitment and enrollment. The Trial Innovation Network is a rapidly developing and evolving collaborative initiative that leverages the expertise, skills and knowledge of the entire CTSA Consortium.

What is the goal of the Trial Innovation Network? The goal of the Trial Innovation Network is to not only execute trials better, faster, and more cost-efficiently but, importantly, to be a national laboratory to study, understand and innovate the process of conducting clinical trials.

What services are offered through the Trial Innovation Network? The Trial Innovation Network currently provides services for multi-center clinical trials and studies.

Who can submit a proposal to the Trial Innovation Network? Full-time faculty at Case Western Reserve University.

How to submit a proposal? Investigators must contact their local Trial Innovation Liaison Team to discuss their proposal and obtain a brief consultation prior to submission. A consultation with the local Trial Innovation Liaison Team is important because these teams will directly connect the local hubs to the national network and provide advice and input on proposals.

Trial innovation
liaison team:

James Chmiel, MD, Co-Medical Director

Lara Jehi, MD, Co-Medical Director

Noreen Roman, MT(ASCP), MBA, Project Coordinator
nroman@metrohealth.org
216.778.3130